The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Chemotherapy-induced peripheral neuropathy is a potentially debilitating adverse effect of cancer therapy that can lead to delay, reduction, or discontinuation of cancer treatment. Population-based ...

In 2018, three back-to-back publications unraveled the role of the gut microbiota—a rich organ within the gastrointestinal tract primarily composed of 10 13 commensal bacteria—in modulating ICI ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Adherence to Adjuvant Endocrine Therapy in Patients With Nonmetastatic Estrogen Receptor–Positive Breast Cancer: A Comprehensive Brazilian Real-World Data Study This prospective observational study ...

Empowering the Next Generation of Cancer Research Advocates: Community Engagement Across the Research Continuum Multicancer early detection tests (MCEDs), sometimes referred to as liquid biopsies, are ...

Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring ...

To compare demographics, clinical characteristics, health care resource utilization (HCRU), treatment duration, and overall survival (OS) with enzalutamide (ENZA) or abiraterone acetate (AA) in ...

Virtual Health Care Encounters for Lung Cancer Screening in a Safety-Net Population: Observations From the COVID-19 Pandemic Requirements for a PRO program were obtained from multiple stakeholders.

Typically, ICIs are administered in infusion centers or clinics, where their cost is covered by outpatient prescription drug coverage plans. Yet, hospitalizations are common among patients with cancer ...

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...

ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent ...